Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 15, 2022 for Docon Technologies Pvt Ltd & API Holdings Ltd Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd Thyrocare Technologies Ltd - 539871 - Schedule Of Analysts/Institutional Investor Meet/Con. Call
our MD & CEO, Mr. Rahul Guha and CFO, Mr. Sachin Salvi, would be attending, on invitation, the following on-going Investor conferences arranged by the following, to be held through Virtual Conferencing: 1) Incred Research Services. 2) Alder Capital 3) Tamohara Investment 4) Mirabilis Investment Trust 5) Nippon Asset Management. Thyrocare Technologies Ltd - 539871 - Clarification Sought By BSE On "Spurt In Volume Of Shares Traded"
With reference to your letter No. L/SURV/ONL/PV/RS/ 2022-2023 / 187 dated September 09, 2022 sent to us by mail, we wish to reply as follows: 1. We have been disclosing all the information / particulars as per the provisions of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. 2. There are no price sensitive information /announcement (including any impending announcement), which in our opinion may have a bearing on the price/volume behaviour in the scrip, and which have not been disclosed. 3. You will agree that such spurt or dip in the volume has become a regular feature not only in our script but also in the scrips of other listed peers. Thyrocare Technologies Ltd - 539871 - Clarification sought from Thyrocare Technologies Ltd
The Exchange has sought clarification from Thyrocare Technologies Ltd on September 9, 2022, with reference to Movement in Volume.The reply is awaited. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Earnings Call held on 02-08-2022 for Analysts / Investors Thyrocare Technologies Ltd - 539871 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Thyrocare Technologies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results and Scrutinizer Report Thyrocare Technologies Ltd - 539871 - Shareholder Meeting / Postal Ballot-Outcome of AGM
22nd Annual General Meeting - Proceedings. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30, read with Schedule III Part A Para A and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith the copies of newspaper advertisement of unaudited financial results for the Quarter ended 30th June 2022, published in Free Press Journal (English) and Pudhari (Marathi) in the prescribed format.